Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients

NCT03535168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough

Interventions

DRUG: BAY1902607
DRUG: Matching placebo
DRUG: Midazolam

Sponsor

Bayer